MICHAEL J. HOSTETLER

Partner
Intellectual Property

EXPERIENCE:

Dr. Mike Hostetler is a partner in the SOMA and San Diego offices of Wilson Sonsini Goodrich & Rosati, where he provides strategic intellectual property counseling to more than 100 growth enterprises in the pharmaceutical and biotechnology, and information technology industries. He works with both venture-backed and public companies. His expertise includes patent strategy, patent prosecution, and patent diligence (both buy and sell side) for venture financings, public offerings, and mergers and acquisitions. He has provided patent counseling in support of pharmaceutical and biotechnology, and information technology products in all stages of development, from proof of concept to regulatory approval to product launch. He leads a talented team of patent associates and patent agents that can meet virtually any technical and strategic need.

Mike currently serves as a member of the firm's Policy and Nominating Committees.

SELECT LIFE SCIENCE REPRESENTATIONS:
  • Amira Pharmaceuticals in intellectual property matters leading to its acquisition by Bristol-Myers Squibb
  • Aragon Pharmaceuticals in intellectual property matters leading to its acquisition by Janssen
  • Ardea Biosciences in intellectual property matters leading to its acquisition by AstraZeneca
  • Avalon Ventures and COI Pharmaceuticals in various intellectual property matters
  • Lumena Pharmaceuticals in intellectual property matters leading to its acquisition by Shire
  • SARcode Bioscience, Inc. in various intellectual property matters leading to its acquisition by Shire
  • Otonomy in intellectual property matters related to its $100 million IPO
  • Pharmacyclics in intellectual property matters leading to its partnership with Janssen for Pharmacyclics’ flagship asset, Imbruvica, as well as in its acquisition by AbbVie
  • Quanticel Pharmaceuticals, PharmAkea Therapeutics, and Abide Therapeutics (all separately backed by venture funding and Celgene) in various intellectual property matters
  • Sanford-Burnham Medical Research Institute in various intellectual property matters
  • Seragon Pharmaceuticals in intellectual property matters leading to its acquisition by Roche/Genentech
SELECT INFORMATION TECHNOLOGY REPRESENTATIONS:
  • Patent strategy architecture and implementation in numerous industries, including educational software, internet security, digital health, virtual reality, web advertising, v-commerce, and quantum computing
  • Patent portfolio risk analysis and risk mitigation strategies on behalf of investors in various information technology sectors
  • Clients include Norse Corporation, Quarri Technologies, Age of Learning, IPS Group, Credit Karma, Collective Health, 1Q Bit Technology, and LendUp
EDUCATION:
  • J.D., Duke University School of Law, 2001
    Order of the Coif; Summa Cum Laude; Grand Prize Winner, Duke Business Plan Competition
  • Ph.D., Chemistry, University of California, Berkeley, 1992
  • B.S., Chemistry, Massachusetts Institute of Technology, 1987
ASSOCIATIONS AND MEMBERSHIPS:
  • Member, Texas Health Catalyst Advisory Panel, The University of Texas at Austin
  • Member, American Bar Association
HONORS:
SELECT PUBLICATIONS:
  • Co-author with V. Norviel, D. Hoffmeister, P. Girinath, D. Van Goor, and C. Andres, "Overcoming Restriction Requirements On Pharma Patents," Law360, August 4, 2015
  • Co-author, "Synthesis and Reactivity of Cp2Ta(CH2)2Ir(CO)2: An Early-Late Heterobimetallic Complex that Catalytically Hydrogenates, Isomerizes, and Hydrosilates Alkenes," Journal of the American Chemical Society 113, 1991
  • Co-author, "Reactions of Primary Organosilanes on Transition Metal Surfaces: Identification of the First Surface-Bound Silylynes," Journal of the American Chemical Society 116, 1994
  • Co-author, "Gold Nanoelectrodes of Varied Size: Transition to Molecule-Like Charging," Science 280, 1998
SELECT SPEAKING ENGAGEMENTS:

Since 2004, Michael has delivered an annual presentation titled "Patent Law in Biomedical Engineering" at the University of California, Irvine, Department of Biomedical Engineering. He has also spoken at QB3@953 and the PlugandPlay Tech Center on patent strategies for the start-up company.

ADMISSIONS:
  • State Bar of California
  • U.S. Patent and Trademark Office

Contact Information

139 Townsend Street
Suite 150
San Francisco, CA 94107
Phone | 858-350-2306
Fax | 866-974-7329

12235 El Camino Real
Suite 200
San Diego, CA 92130
Phone | 858-350-2300
Fax | 858-350-2399

Email | Michael Hostetlermhostetler@wsgr.com


Areas of Expertise

Print to PDF